Canada Post Xpresspost1–2 day delivery across CanadaFree on orders over $200
NA-Selank, 10mg, lyophilized research peptide vial, Eppix Labs
Certificate of Analysis — 10mgCertificate of Analysis for NA-Selank 10mg
Chemical StructureNA-Selank chemical structure
Amino Acid SequenceNA-Selank amino acid chain
Latest COA

Buy NA-Selank Canada | N-Acetyl Selank 10mg

Janoshik

Batch NSLK-CA-26G-10

Result2026-08-17
Added2026-08-17
Avg Purity99.712%
Avg Mass11.88 mg
Verify on Janoshik
Formula
C35H59N11O10
Mol. weight
793.9 g/mol
Form
Lyophilized powder
Tested by
Janoshik
In StockCognitive
BatchNSLK-CA-26G-10

NA-Selank Canada — 10 mg Lyophilized Vials, Janoshik-Tested

Tuftsin-Analogue Anxiolytic Peptide

Also known as N-Acetyl Selank (Selank analogue)

N-Acetyl Selank is an N-acetylated form of Selank, a synthetic heptapeptide analogue of the immunomodulatory peptide tuftsin, studied in research for anxiolytic and neuromodulatory signaling.

$60.00CAD

Mix & Match

1 vial — no vial discount yet.

Add 2 more vials for 5% off.

After that, 10% at 5 vials, 20% at 10 vials.

Purity VerifiedLab TestedSecure
Research Use Only

This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.

By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.

N-Acetyl Selank is an N-acetylated form of Selank, a synthetic heptapeptide analogue of the immunomodulatory peptide tuftsin, studied in research for anxiolytic and neuromodulatory signaling.

Experimental models examine its peptidergic activity under controlled laboratory conditions.

Purity

Third-party tested for purity, ID, quantity.

Amino Acid Sequence
Amino acid chain diagram
Chemical Structure
Chemical structure diagram
Compound Properties
Molecular FormulaC35H59N11O10
Molecular Weight793.9 g/mol
PubChem CID133082488

Overview

Selank is a synthetic tuftsin analogue characterized in research for anxiolytic and neuromodulatory activity, including effects on GABAergic and monoaminergic signaling and on neurotrophic-factor expression. The N-acetylated form is studied for its peptide stability profile within the same research framework.

Studies span anxiolytic-model and neuroprotection research under structured conditions.

History

Selank was developed from research into stable analogues of the endogenous peptide tuftsin with neuromodulatory activity.

Research has characterized its anxiolytic and memory-related endpoints in model systems; the N-acetyl form shares this lineage.

Key Research Areas

Research into Selank-class peptides focuses on anxiolytic and neuromodulatory models. Frameworks evaluate peptidergic signaling, anxiolysis, and neurotrophic endpoints under controlled preclinical conditions.

3 of the 4 areas below are addressed directly by a paper cited on this page.

Tuftsin-analogue peptide models

Addressed on this page by Kolik 2019, Konstantinopolsky 2022, Vyunova 2018. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.

  • Kolik, LG. et al. (2019) Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats
  • Konstantinopolsky, MA. et al. (2022) Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats
  • Vyunova, TV. et al. (2018) Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity

Anxiolytic-signaling research

Addressed on this page by Vyunova 2018. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.

Neurotrophic and memory studies

Addressed on this page by Kolik 2019. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.

  • Kolik, LG. et al. (2019) Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats

Neuromodulation frameworks

No paper cited on this page reports on neuromodulation. This heading marks where NA-Selank is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.

The references section of this page cites 3 primary papers published between 2018 and 2022 — a thin record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.

Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for NA-Selank, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.

Also called

NA-Selank is also referred to as NA-selank, acetyl selank, and technically as N-Acetyl Selank (Selank analogue).

Preclinical only

NA-Selank is commonly described online in connection with sharper focus, better memory and improved mood. In the research literature the same compound is filed under tuftsin-analogue peptide models, anxiolytic-signaling research and neurotrophic and memory studies.

The 3 papers cited on this page, published between 2018 and 2022 (2 in animal models) describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.

Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.

Verification for NA-Selank is per lot, not per product. The current 10mg lot NSLK-CA-26G-10 returned 99.712% purity, 11.88 mg measured, 118.8% of the labelled 10 mg, assayed by Janoshik. Those figures are the laboratory's, published in full rather than reduced to a badge.

Purity is half the number. It states what fraction of the material in the vial is NA-Selank; it says nothing about how much material is in the vial, and a short-filled vial can return a purity result that is entirely accurate. The figure that answers the second question is measured mass against expected content — for NA-Selank, this lot measured 118.8% of its labelled 10 mg. Both numbers are published for every lot, whichever way they fall.

The lot code printed on the vial matches the code on the certificate for NA-Selank. Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.

Researchers who buy NA-Selank in Canada through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.

Verify a batch code →

Lyophilized storage
−20 °C long-term; stable at room temperature in transit
After reconstitution
2–8 °C
Light
Protect from UV and direct light
Freeze-thaw
Avoid repeated cycles
Vehicle
Bacteriostatic water in most published protocols
Format
Lyophilized powder

NA-Selank is supplied as lyophilized powder. In the dry state the material is comparatively stable, which is why it ships at ambient temperature without a cold chain; once reconstituted it is a peptide in solution and the handling constraints tighten considerably. At 7 residues it is short enough to be produced by solid-phase synthesis, and the published sequence on this page is what an identity assay is checked against.

Repeated freeze-thaw cycling is the handling error most likely to degrade material of this class, because each cycle concentrates solutes at the ice boundary. Where a protocol calls for the same vial across multiple sessions, the published literature generally describes aliquoting after reconstitution rather than re-freezing the whole volume.

Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.

Reconstitution calculator →

Included
  • 1 × sealed glass vial in the strength selected (10mg / Single Vial, 10mg / 5-Pack, 10mg / 10-Pack available), batch-labelled
  • The batch-linked Certificate of Analysis for the exact lot shipped
  • Discreet outer packaging with no product names on the exterior
  • Canada Post Xpresspost, tracked, typically 1–2 business days from Canadian stock
Not included
  • Bacteriostatic water or any other reconstitution vehicle
  • Syringes, needles or filters
  • Dosing, administration or protocol guidance of any kind

Reconstitution materials are sourced separately. The reconstitution calculator on this site works out concentrations for a given volume, but it is an arithmetic tool for laboratory record-keeping and not a protocol.

No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.

Each unit contains the labeled quantity of n acetyl selank. Independent third-party analysis verifies purity, identity, and net content per batch.

The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.

Duration depends entirely on research design, storage conditions, and laboratory protocol.

Vyunova, TV. et al.(2018)

Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity

PubMed
Konstantinopolsky, MA. et al.(2022)

Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats

PubMed
Kolik, LG. et al.(2019)

Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats

PubMed

Related

Researchers also order

Retatrutide 10 mg research peptide vial — Eppix Labs CanadaSale

Metabolic & GLP-1

Retatrutide

Next-generation GLP receptor agonist studied for metabolic signaling and nutrient partitioning pathways

RETA-CA-26E-0199.637%

11.76 mg / 10 mg

$60.00$70.00CAD

Tirzepatide 10 mg research peptide vial — Eppix Labs CanadaSale

Metabolic & GLP-1

Tirzepatide

Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research

TIRZ-CA-26G-1099.634%

11.42 mg / 10 mg

$35.00$40.00CAD

Semaglutide 10 mg research peptide vial — Eppix Labs Canada

Metabolic & GLP-1

Semaglutide

Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.

10 mg

SEMA-CA-26F-1099.504%

11.27 mg / 10 mg

$70.00CAD

Eloralintide (LY3841136) 10 mg research peptide vial — Eppix Labs Canada

Metabolic & GLP-1

Eloralintide (LY3841136)

This product is supplied as eloralintide (LY3841136), a long-acting, selective amylin receptor agonist studied in research on metabolic and body-weight regulation.

10 mg

ELOR-CA-26G-1099.810%

12.42 mg / 10 mg

$150.00CAD

Support

Need help?

Have questions about batch verification, documentation, or research specifications? Our team is available to assist with product and compliance inquiries.